PlexusDx vs BrightMeds: Is the Lowest Advertised Price the Best Deal?

Last reviewed: September 5, 2026 Last updated: September 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

BrightMeds holds the lowest advertised per-month rates we have verified: prepaid 3-month plans priced at $99/month for semaglutide and $119/month for tirzepatide (captured September 4, 2026). Those figures require full upfront payment—$297 and $357 respectively—and appear as part of a state-limited summer promotional campaign. BrightMeds' standard month-to-month rates are $129 and $149. PlexusDx runs $189/month and $289/month month-to-month for the same compounds, with no membership fees on either side. Over twelve months the BrightMeds prepaid structure saves $600 on semaglutide and $1,560 on tirzepatide compared with PlexusDx's best prepaid option. BrightMeds carries a 4.8-star Trustpilot rating from over 900 reviews; PlexusDx holds a 4.2-star rating with 76 percent of reviews at five stars. If you qualify in an eligible state and can prepay quarterly, BrightMeds delivers the lowest sustained cost in this comparison. If you prefer month-to-month flexibility or live outside the promotional footprint, PlexusDx offers broader availability and no prepayment requirement.

At-a-glance comparison

BrightMeds pricing captured September 4, 2026; PlexusDx pricing captured July 17–23, 2026 and verified September 4, 2026. Per-month figures for prepaid plans are our calculation.

Normalized 12-month cost analysis

Advertised per-month figures can obscure the true recurring expense, especially when prepayment or promotional periods are involved. Below we calculate total annual spending under three scenarios, using only figures captured from each provider's website and labeling every derived sum.

Scenario A: Month-to-month plans

If you pay monthly with no upfront commitment:

BrightMeds

• Semaglutide: $129/month × 12 = $1,548/year (our calculation)
• Tirzepatide: $149/month × 12 = $1,788/year (our calculation)

PlexusDx

• Semaglutide: $189/month × 12 = $2,268/year (our calculation)
• Tirzepatide: $289/month × 12 = $3,468/year (our calculation)

Annual difference: BrightMeds saves $720 on semaglutide and $1,680 on tirzepatide (our calculation) when both programs are compared month-to-month.

Scenario B: Maximum multi-month commitment

BrightMeds offers 3-month prepaid cycles; PlexusDx offers up to 6-month prepaid. To model a full year, BrightMeds requires four quarterly payments and PlexusDx requires two six-month payments.

BrightMeds (four 3-month cycles)

• Semaglutide: $297 × 4 = $1,188/year (our calculation), or $99/month
• Tirzepatide: $357 × 4 = $1,428/year (our calculation), or $119/month

PlexusDx (two 6-month cycles)

• Semaglutide: $894 × 2 = $1,788/year (our calculation), or $149/month
• Tirzepatide: $1,494 × 2 = $2,988/year (our calculation), or $249/month

Annual difference: BrightMeds saves $600 on semaglutide and $1,560 on tirzepatide (our calculation) when both programs are compared at their best prepaid rates.

Scenario C: Like-for-like 3-month plans

Both providers offer a 3-month prepaid option. Direct comparison:

Semaglutide

• BrightMeds: $297 upfront ($99/month, our calculation)
• PlexusDx: $507 upfront ($169/month, our calculation)
• BrightMeds costs $210 less per quarter, or $70/month savings (our calculation)

Tirzepatide

• BrightMeds: $357 upfront ($119/month, our calculation)
• PlexusDx: $807 upfront ($269/month, our calculation)
• BrightMeds costs $450 less per quarter, or $150/month savings (our calculation)

Across every plan structure—month-to-month, maximum prepaid, and like-for-like quarterly—BrightMeds delivers the lower total cost. The gap is widest on tirzepatide and narrows slightly on semaglutide, but BrightMeds wins every pairing.

What the pricing structure reveals

BrightMeds' advertised $99 and $119 per-month rates require full quarterly prepayment and appear under a summer promotional campaign that is limited by state. The promotional nature means availability may change when the campaign ends, and not every U.S. state is included. Standard month-to-month rates—$129 semaglutide, $149 tirzepatide—are still lower than PlexusDx but sit $30 to $140 per month above the headline prepaid figures depending on compound.

PlexusDx pricing is uniform across states where telemedicine prescribing is permitted, carries no promotional expiration, and offers month-to-month, 3-month, and 6-month plans. The month-to-month rate is higher, but it avoids upfront commitment and the risk that a promotional rate disappears mid-treatment.

Neither program charges a separate membership fee. Both include shipping, provider access, and dose adjustments at the published price. BrightMeds explicitly lists "evaluation, follow-up, adjustments, support" in its inclusions; PlexusDx lists "medication, provider access, shipping." The practical service bundle is similar; the labeling differs.

Service ratings and user feedback

BrightMeds displays a 4.8-star Trustpilot rating with over 900 reviews (captured September 4, 2026 from the provider's website). PlexusDx holds a 4.2-star rating on Trustpilot, with 76 percent of reviews at five stars and 81 percent at four stars or higher (captured September 4, 2026).

BrightMeds' higher rating and larger review volume suggest strong user satisfaction at scale. We did not identify coded negative themes in the evidence available for this comparison; the rating advantage is clear in the aggregate numbers. No provider can guarantee individual outcomes, and review platforms reflect self-selected experiences rather than controlled samples.

Decision factors that matter beyond the monthly rate

Geographic and promotional constraints

BrightMeds' lowest rates are tied to a state-limited summer promotion. If you live outside the eligible states or if the promotion ends before you start, you will pay the standard month-to-month rate or lose access to the program entirely. Confirm state eligibility and promotional status at checkout before committing to a prepaid plan.

Prepayment risk

Quarterly prepayment locks in the lowest per-month rate but removes flexibility. If you experience side effects, need to pause treatment, or want to switch compounds, the prepaid dollars are already spent. Neither provider's refund or cancellation policy was specified in the sources we reviewed. If flexibility matters more than cost minimization, month-to-month plans—while more expensive—preserve the option to stop or adjust without sunk cost.

Dose ceilings and titration

Both programs state "any dose, same price." That language suggests no surcharge as you titrate from starting doses (0.25 mg semaglutide, 2.5 mg tirzepatide) to maintenance doses (1–2.4 mg semaglutide, 5–15 mg tirzepatide). Confirm at intake whether the program covers the full FDA-studied dose range for the branded reference products; some compounding providers cap supply below maintenance levels.

Compounding and FDA status

Both programs dispense compounded GLP-1 medications. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. Do not assume compounded semaglutide or tirzepatide is interchangeable with Wegovy, Ozempic, Mounjaro, or Zepbound in formulation, sterility assurance, or dosing precision.

Choose BrightMeds if…

• You live in a state included in the summer promotional footprint and can verify eligibility before you start.
• You can prepay $297 (semaglutide) or $357 (tirzepatide) every three months and want the lowest per-month rate we have verified in the telemedicine GLP-1 market.
• You prioritize a higher aggregate Trustpilot rating and a larger review sample when selecting a provider.
• You are comfortable with the promotional time limit and understand the rate may revert to the standard month-to-month figure if the campaign ends.

Choose PlexusDx if…

• You prefer month-to-month billing with no quarterly prepayment and are willing to pay a higher per-month rate for that flexibility.
• You want a non-promotional rate structure that does not depend on campaign timing or state-specific offers.
• You value a 6-month prepaid option—longer than BrightMeds' maximum 3-month cycle—and want to lock in $149/month semaglutide or $249/month tirzepatide over two cycles per year.
• You want to work with a provider that publishes transparent comparison research and applies the same evidence standard to its own program and competitors.

Methodology and freshness

We captured BrightMeds pricing and promotional details from the provider's website on September 4, 2026 at 13:49:55 UTC. PlexusDx pricing was verified from internal records effective 2026 and cross-checked against public product pages captured July 17–23, 2026 and re-verified September 4, 2026. Trustpilot ratings for both providers were captured September 4, 2026.

All per-month figures for prepaid plans and all annual totals are our calculation, derived by multiplying the verified prepaid price by the number of cycles required to cover twelve months. We label every calculated figure. When a source states a per-month rate (e.g., "$99/month" for a $297 quarterly charge), we report both the rate language and the actual prepaid total so the upfront commitment is transparent.

No promotional codes, affiliate links, or undisclosed relationships influence this comparison. PlexusDx publishes the research and is one of the programs discussed; we apply identical evidence rules to our own pricing and competitors' pricing.

Frequently Asked Questions

Is BrightMeds' $99/month semaglutide rate available month-to-month or only prepaid?

The $99/month figure is a per-month rate that requires $297 prepaid for three months. BrightMeds' standard month-to-month rate is $129/month for semaglutide. The prepaid rate is part of a state-limited summer promotion, so confirm both geographic eligibility and promotional status before you commit.

Does PlexusDx charge extra when my dose increases?

No. PlexusDx pricing is the same at every dose level. Whether you are starting at 0.25 mg semaglutide or maintaining at 2.4 mg, the monthly cost remains $189 on the month-to-month plan, $169 on the 3-month plan, or $149 on the 6-month plan.

Can I switch from BrightMeds to PlexusDx mid-treatment without restarting titration?

Transferring between providers typically requires a new intake and clinical review. A licensed provider will assess your current dose, tolerance, and goals, but cannot guarantee you will resume at the same dose or compound. If you have prepaid a BrightMeds quarter and want to switch, confirm whether any unused portion is refundable before you cancel.

Which program covers higher tirzepatide doses—10 mg, 12.5 mg, or 15 mg?

Both BrightMeds and PlexusDx state "any dose, same price," but neither source specifies an upper dose limit. The FDA-approved tirzepatide products (Mounjaro, Zepbound) are studied up to 15 mg weekly. Confirm at intake that your target maintenance dose is available through the compounding pharmacy before you prepay or start treatment.

Are compounded GLP-1 medications as safe and effective as Wegovy or Mounjaro?

Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. Compounded semaglutide and tirzepatide use the same active pharmaceutical ingredient as branded products but may differ in formulation, excipients, sterility assurance, and dosing precision.

Sources

• PlexusDx public pricing pages and internal pricing records, captured and verified July 17–23, 2026 and September 4, 2026
• BrightMeds promotional pricing page (brightmeds.com/summer-special), captured September 4, 2026 at 13:49:55 UTC
• Trustpilot ratings for PlexusDx and BrightMeds, captured September 4, 2026
• PlexusDx instructions and standing disclosure requirements, effective 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.